The death effector domain-containing DEDD forms a complex with Akt and Hsp90, and supports their stability

Biochemical and Biophysical Research Communications

Volumn 391, Issue 4, 2010, Pages 1708-1713

  Kurabe, Nobuya ^a   Mori, Mayumi ^a   Kurokawa, Jun ^a   Taniguchi, Kaori ^a   Aoyama, Hisatoshi ^a   Atsuda, Kazuhiro ^a   Nishijima, Akemi ^a   Odawara, Nariaki ^a   Harada, Saori ^a   Nakashima, Katsuhiko ^a   Arai, Satoko ^a   Miyazaki, Toru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Akt; Cdk1; DEDD; Glucose uptake

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 1 INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR; DEATH EFFECTOR DOMAIN CONTAINING DEDD PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER 4; HEAT SHOCK PROTEIN 90; INSULIN; PROTEIN KINASE B; REGULATOR PROTEIN; S6 KINASE; S6 KINASE 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME REPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; INSULIN RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HSP90 HEAT-SHOCK PROTEINS; INSULIN; MICE; MICE, MUTANT STRAINS; MUSCLE, SKELETAL; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA;

MUS;

EID: 74449091175     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.137     Document Type: Article

References (40)

1. Jacinto E., and Hall M.N. Tor signalling in bugs, brain and brawn. Nat. Rev. Mol. Cell. Biol. 4 (2003) 117-126
2. Oldham S., and Hafen E. Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. Trends Cell Biol. 13 (2003) 79-85
3. Valentinis B., and Baserga R. IGF-I receptor signalling in transformation and differentiation. Mol. Pathol. 54 (2001) 133-137
4. Vogt P.K. PI 3-kinase, mTOR, protein synthesis and cancer. Trends Mol. Med. 7 (2001) 482-484
5. Fingar D.C., and Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23 (2004) 3151-3171
6. Huang S., and Houghton P.J. Targeting mTOR signaling for cancer therapy. Curr. Opin. Pharmacol. 3 (2003) 371-377
7. Shamji F., Nghiem P., and Schreiber S.L. Integration of growth factor and nutrient signaling: implications for cancer biology. Mol. Cell 12 (2003) 271-280
8. Vivanco, and Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2 (2002) 489-501
9. Pende M., Kozma S.C., Jaquet M., et al. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 408 (2000) 994-997
10. Dann S.G., Selvaraj A., and Thomas G. mTOR complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol. Med. 13 (2007) 252-259
11. Um S.H., D'Alessio D., and Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 3 (2006) 393-402
12. Hill M.M., Clark S.F., Tucker D.F., et al. A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes. Mol. Cell. Biol. 19 (1999) 7771-7781
13. Huang S., and Czech M.P. The GLUT4 glucose transporter. Cell Metab. 5 (2007) 237-252
14. Summers S.A., Garza L.A., Zhou H., and Birnbaum M.J. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol. Cell. Biol. 18 (1998) 5457-5464
15. Whiteman E.L., Cho H., and Birnbaum M.J. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13 (2002) 444-451
16. Bell G.I., and Polonsky K.S. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414 (2001) 788-791
17. DeFronzo R.A. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5 (1997) 177
18. Kahn B.B., and Rossetti L. Type 2 diabetes-who is conducting the orchestra?. Nat. Genet. 20 (1998) 223-225
19. Kurabe N., Arai S., Nishijima A., et al. The death effector domain-containing DEDD supports S6K1 activity via preventing Cdk1-dependent inhibitory phosphorylation. J. Biol. Chem. 284 (2009) 5050-5055
20. Stegh H., Schickling O., Ehret A., et al. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J. 17 (1998) 5974-5986
21. Arai S., Miyake K., Voit R., et al. The death-effector domain containing protein DEDD is a novel mitotic inhibitor requisite for cell growth. Proc. Natl. Acad. Sci. USA 104 (2007) 2289-2294
22. Miyazaki T., and Arai S. Two distinct controls of mitotic Cdk1/cyclin B1 requisite for cell growth prior to cell division. Cell Cycle 6 (2007) 1419-1425
23. Papst P.J., Sugiyama .H., Nagasawa M., et al. Cdc2-cyclin B phosphorylates p70 S6 kinase on Ser411 at mitosis. J. Biol. Chem. 273 (1998) 15077-15084
24. Shah O.J., Ghosh S., and Hunter T. J. Biol. Chem. 278 (2003) 16433-16442
25. Kamei N., Tobe K., Suzuki R., et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 281 (2006) 26602-26614
26. Bogan S., McKee A.E., and Lodish H.F. Insulin-responsive compartments containing GLUT4 in 3T3-L1 and CHO cells: regulation by amino acid concentrations. Mol. Cell. Biol. 21 (2001) 4785-4806
27. Jiang Z.Y., Chawla A., Bose A., et al. A phosphatidylinositol 3-kinase-independent insulin signaling pathway to N-WASP/Arp2/3/F-actin required for GLUT4 glucose transporter recycling. J. Biol. Chem. 277 (2002) 509-515
28. Basso D., Solit D.B., Chiosis G., et al. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 277 (2002) 39858-39866
29. Solit D.B., Basso A.D., Olshen A.B., et al. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res. 63 (2003) 2139-2144
30. Brazil D.P., Yang Z.Z., and Hemmings B.A. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29 (2004) 233-242
31. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
32. Du K., and Tsichlis P.N. Regulation of the Akt kinase by interacting proteins. Oncogene 24 (2005) 7401-7409
33. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292 (2001) 1728-1731
34. Garofalo R.S., Orena S.J., Rafidi K., et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest. 112 (2003) 197-208
35. Ng Y., Ramm G., Lopez J.A., and James D.E. Rapid activation of Akt2 is sufficient to stimulate GLUT4 translocation in 3T3-L1 adipocytes. Cell Metab. 7 (2008) 348-356
36. Hunter T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28 (2007) 730-738
37. Suizu F., Hiramuki Y., Okumura F., et al. The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. Dev. Cell 17 (2009) 800-810
38. Dickey C.A., Koren J., Zhang Y., et al. Akt and CHIP coregulate tau degradation through coordinated interactions. Proc. Natl. Acad. Sci. USA 105 (2008) 3622-3627
39. Facchinetti V., Ouyang W., Wei H., et al. The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27 (2008) 1932-1943
40. Xiang T., Ohashi A., Huang Y., et al. Negative Regulation of AKT Activation by BRCA. Cancer Res. 168 (2008) 10040-10044